Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2019

01-10-2019 | Research Article

Healthcare personnel’s experience of reporting adverse drug reactions in Baghdad city: cross-sectional study

Authors: Saad Abdulrahman Hussain, Ashwaq Nagemeldeen Abbas, Shah-Zanan Alaa Habeeb, Athraa Kareem Abd-Ali, Zainab Saad Abdulrahman

Published in: International Journal of Clinical Pharmacy | Issue 5/2019

Login to get access

Abstract

Background Adverse drug reactions (ADRs) are undesirable effects to drugs at doses normally used in the clinical setting for diagnosis, treatment or prophylaxis of diseases. Spontaneous ADR reporting is currently considered as a critical part of ADRs detection. Objective The study aims to assess the knowledge, attitude, and practice of healthcare providers towards adverse drug reaction reporting in public and private settings within the Baghdad area. Method We follow a quantitative cross-sectional study design, using a self-administered questionnaire to collect data from the healthcare providers regarding their reporting practice. Main outcome The outcome measures include the experiences of reporting of adverse drug reactions and the available systems, in addition to the expected benefits to clinical practice. Results Among 485 respondents, 114 were able to differentiate ADRs from side effects. About half of them (47.6%) recognized the availability of reporting systems and 43.3% knew how to report adverse drug reactions. 43.7% of the respondents mentioned that ADRs should be reported only when they are life-threatening. Among the 188 respondents who encountered ADRs, 145 reported the events to the accessible local authority. Conclusion The healthcare providers working in Baghdad healthcare institutions have a good attitude toward ADR reporting. There is a relatively below-standard reporting culture of the encountered adverse reactions. The inadequate knowledge about adverse reactions and the unavailability of reporting forms played a major role in discouraging healthcare professionals to detect and report ADRs.
Literature
1.
go back to reference Gautron S, Wentzell J, Kanji S, Nguyen T, Kobewka DM, MacDonald E. Characterization of serious adverse drug reactions in the hospital to determine potential implications of mandatory reporting. Can J Hosp Pharm. 2018;71(5):316–23.PubMedPubMedCentral Gautron S, Wentzell J, Kanji S, Nguyen T, Kobewka DM, MacDonald E. Characterization of serious adverse drug reactions in the hospital to determine potential implications of mandatory reporting. Can J Hosp Pharm. 2018;71(5):316–23.PubMedPubMedCentral
2.
go back to reference Li R, Curtain C, Bereznicki L, Zaidi STR. Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey. Int J Clin Pharm. 2018;40(4):878–89.CrossRef Li R, Curtain C, Bereznicki L, Zaidi STR. Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey. Int J Clin Pharm. 2018;40(4):878–89.CrossRef
3.
go back to reference Ahmad A, Patel I, Balkrishnan R, Mohanta G, Manna P. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: a pilot study. Perspect Clin Res. 2013;4(4):204–410.CrossRef Ahmad A, Patel I, Balkrishnan R, Mohanta G, Manna P. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: a pilot study. Perspect Clin Res. 2013;4(4):204–410.CrossRef
4.
go back to reference Mascolo A, Scavone C, Sessa M, et al. Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting. Pharmacol Res. 2017;123:122–9.CrossRef Mascolo A, Scavone C, Sessa M, et al. Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting. Pharmacol Res. 2017;123:122–9.CrossRef
5.
go back to reference Pirmohamad M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. Br Med J. 2004;329:15–9.CrossRef Pirmohamad M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. Br Med J. 2004;329:15–9.CrossRef
6.
go back to reference Pirmohamed M, Breckenridge A, Kitteringham N, Park B. Fortnightly review. Adverse drug reactions. Br Med J. 1998;316:1295–8.CrossRef Pirmohamed M, Breckenridge A, Kitteringham N, Park B. Fortnightly review. Adverse drug reactions. Br Med J. 1998;316:1295–8.CrossRef
7.
go back to reference Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE. 2009;4:e4439.CrossRef Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE. 2009;4:e4439.CrossRef
8.
go back to reference Saha L. Role of pharmacovigilance in drug development. Enliven Pharmacovigil Drug Saf. 2014;1(1):9–10.CrossRef Saha L. Role of pharmacovigilance in drug development. Enliven Pharmacovigil Drug Saf. 2014;1(1):9–10.CrossRef
9.
go back to reference Ponmari SJ, Sivaraman M, Aruna T, Subashree V. Knowledge and awareness of pharmacovigilance among various medical fraternities. Asian J Pharmacol Toxicol. 2015;03(10):45–8. Ponmari SJ, Sivaraman M, Aruna T, Subashree V. Knowledge and awareness of pharmacovigilance among various medical fraternities. Asian J Pharmacol Toxicol. 2015;03(10):45–8.
10.
go back to reference Williams D, Feely J. Underreporting of adverse drug reactions: attitudes of Irish doctors. Ir J Med Sci. 1999;168:257–61.CrossRef Williams D, Feely J. Underreporting of adverse drug reactions: attitudes of Irish doctors. Ir J Med Sci. 1999;168:257–61.CrossRef
11.
go back to reference Black N. Why we need observational studies to evaluate the effectiveness of health care. Br Med J. 2011;312:1215–8.CrossRef Black N. Why we need observational studies to evaluate the effectiveness of health care. Br Med J. 2011;312:1215–8.CrossRef
12.
go back to reference Aagaard L, Soendergaard B, Stenver DI, Hansen EH. Knowledge creation about ADRs-turning the perspective from the rear mirror to the projector. Br J Clin Pharmacol. 2008;65:364–76.CrossRef Aagaard L, Soendergaard B, Stenver DI, Hansen EH. Knowledge creation about ADRs-turning the perspective from the rear mirror to the projector. Br J Clin Pharmacol. 2008;65:364–76.CrossRef
13.
go back to reference Tyrer S, Heyman B. Sampling in epidemiological research: issues, hazards, and pitfalls. BJPsych Bull. 2016;40(2):57–60.CrossRef Tyrer S, Heyman B. Sampling in epidemiological research: issues, hazards, and pitfalls. BJPsych Bull. 2016;40(2):57–60.CrossRef
14.
go back to reference Kamtane RA, Jayawardhani V. Knowledge, attitude and perception of physicians towards adverse drug reaction (ADR) reporting: a pharmacoepidemiological study. Asian J Pharm Clin Res. 2012;5(3):210–4. Kamtane RA, Jayawardhani V. Knowledge, attitude and perception of physicians towards adverse drug reaction (ADR) reporting: a pharmacoepidemiological study. Asian J Pharm Clin Res. 2012;5(3):210–4.
15.
go back to reference Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK. A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015;6(1):45.CrossRef Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK. A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015;6(1):45.CrossRef
16.
go back to reference Okada K. Bayesian meta-analysis of Cronbach’s coefficient alpha to evaluate informative hypotheses. Res Synth Methods. 2015;6(4):333–46.CrossRef Okada K. Bayesian meta-analysis of Cronbach’s coefficient alpha to evaluate informative hypotheses. Res Synth Methods. 2015;6(4):333–46.CrossRef
17.
go back to reference Opadeyi AO, Fourrier-Réglat A, Isah AO. An educational intervention to improve the knowledge, attitude, and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria. Ther Adv Drug Saf. 2019;10:2042098618816279.CrossRef Opadeyi AO, Fourrier-Réglat A, Isah AO. An educational intervention to improve the knowledge, attitude, and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria. Ther Adv Drug Saf. 2019;10:2042098618816279.CrossRef
18.
go back to reference Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients: a systematic review of the prospective and retrospective studies. Bandolier Extra. 2002;101(4):1–15. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients: a systematic review of the prospective and retrospective studies. Bandolier Extra. 2002;101(4):1–15.
19.
go back to reference Mukattash TL, Alwadi MW, Abu-Farha RK, Jarab AS, Al-Zubiedi SA, Alwedyan T. Knowledge, attitudes, and practices of pharmacovigilance and ADRs spontaneous reporting among pediatricians and pediatric residents in Jordan. Curr Clin Pharmacol. 2018;13(1):45–54.CrossRef Mukattash TL, Alwadi MW, Abu-Farha RK, Jarab AS, Al-Zubiedi SA, Alwedyan T. Knowledge, attitudes, and practices of pharmacovigilance and ADRs spontaneous reporting among pediatricians and pediatric residents in Jordan. Curr Clin Pharmacol. 2018;13(1):45–54.CrossRef
20.
go back to reference AlShammari TM, Almoslem MJ. Knowledge, attitudes and practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-center cross-sectional study. Saudi Pharm J. 2018;26(7):925–31.CrossRef AlShammari TM, Almoslem MJ. Knowledge, attitudes and practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-center cross-sectional study. Saudi Pharm J. 2018;26(7):925–31.CrossRef
21.
go back to reference Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost of illness model. J Am Pharm Assoc (Wash). 2001;41(2):192–9.CrossRef Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost of illness model. J Am Pharm Assoc (Wash). 2001;41(2):192–9.CrossRef
22.
go back to reference Angamo MT, Wabe NT. Knowledge, attitude and practice of adverse drug reaction reporting among health professionals in South West Ethiopia. TAF Prev Med Bull. 2012;11(4):397–406.CrossRef Angamo MT, Wabe NT. Knowledge, attitude and practice of adverse drug reaction reporting among health professionals in South West Ethiopia. TAF Prev Med Bull. 2012;11(4):397–406.CrossRef
23.
go back to reference Abatemarco D, Perera S, Bao SH, et al. Training augmented intelligent capabilities for pharmacovigilance: applying deep-learning approaches to individual case safety report processing. Pharmaceut Med. 2018;32(6):391–401.PubMedPubMedCentral Abatemarco D, Perera S, Bao SH, et al. Training augmented intelligent capabilities for pharmacovigilance: applying deep-learning approaches to individual case safety report processing. Pharmaceut Med. 2018;32(6):391–401.PubMedPubMedCentral
24.
go back to reference Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf. 2010;19(3):217–22.CrossRef Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf. 2010;19(3):217–22.CrossRef
25.
go back to reference Kazeam A, Jacob O. Perceptions of doctors to adverse drug reaction reporting in a teaching Hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14. Kazeam A, Jacob O. Perceptions of doctors to adverse drug reaction reporting in a teaching Hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14.
26.
go back to reference Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2006;29(4):331–40.CrossRef Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2006;29(4):331–40.CrossRef
27.
go back to reference Sabblah GT, Akweongo P, Darko D, Dodoo AN, Sulley AM. Adverse drug reaction reporting by doctors in a developing country: a case study from Ghana. Ghana Med J. 2014;48(4):189–93.CrossRef Sabblah GT, Akweongo P, Darko D, Dodoo AN, Sulley AM. Adverse drug reaction reporting by doctors in a developing country: a case study from Ghana. Ghana Med J. 2014;48(4):189–93.CrossRef
28.
go back to reference Alshammari TM, Alamri KK, Ghawa YA, Alohali NF, Abualkol SA, Aljadhey HS. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia. Int J Clin Pharm. 2015;37(6):1104–10.CrossRef Alshammari TM, Alamri KK, Ghawa YA, Alohali NF, Abualkol SA, Aljadhey HS. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia. Int J Clin Pharm. 2015;37(6):1104–10.CrossRef
29.
go back to reference Toklu HZ, Uysal MK. Knowledge and attitude of Turkish community pharmacists towards pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62.CrossRef Toklu HZ, Uysal MK. Knowledge and attitude of Turkish community pharmacists towards pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62.CrossRef
30.
go back to reference Fincham JE. Response rates and responsiveness for surveys, standards, and the Journal. Am J Pharm Educ. 2008;72(2):43.CrossRef Fincham JE. Response rates and responsiveness for surveys, standards, and the Journal. Am J Pharm Educ. 2008;72(2):43.CrossRef
Metadata
Title
Healthcare personnel’s experience of reporting adverse drug reactions in Baghdad city: cross-sectional study
Authors
Saad Abdulrahman Hussain
Ashwaq Nagemeldeen Abbas
Shah-Zanan Alaa Habeeb
Athraa Kareem Abd-Ali
Zainab Saad Abdulrahman
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 5/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00867-7

Other articles of this Issue 5/2019

International Journal of Clinical Pharmacy 5/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.